Pediatric fentanyl ED cases underscore need for harm reduction: Study

Advertisement

One in five pediatric patients who tested positive for fentanyl after a nonmedical exposure at two California emergency departments needed mechanical ventilation, according to a retrospective study published Nov. 15 in Cureus.

Francisco Ibarra Jr., PharmD, of Community Regional Medical Center in Fresno and the University of California San Francisco Fresno, and Negin Fadaee, a medical student at California Health Sciences University College of Osteopathic Medicine in Clovis, looked at emergency department encounters at two sites in California’s Central Valley. They included patients 18 and younger whose urine drug screen was positive for fentanyl within 24 hours of arrival, from September 2023 through August 2025. Of 172 charts reviewed, 157 were excluded because the patient had received fentanyl before testing. That left 15 patients.

Three patients needed mechanical ventilation, three were admitted to the ICU and one arrived in cardiac arrest and required cardiopulmonary resuscitation. No patients died. Eight were discharged directly from the ED, and four were placed on psychiatric holds.

Six patients got intranasal naloxone before reaching the hospital.

Six exposures were unintentional. Many involved counterfeit pills the patients thought were oxycodone-acetaminophen or alprazolam.

Many patients had more than one substance in their system. Seven tested positive for cannabis, three for cocaine and three for benzodiazepines.

The study sites began fentanyl-specific testing in September 2023. That let researchers identify cases from toxicology results instead of the administrative billing codes earlier studies relied on, which can miss fentanyl exposures.

The researchers called for harm reduction strategies, including:

  • Naloxone distribution
  • Education about counterfeit medications containing fentanyl
  • Safe medication storage
  • Better access to pediatric mental health and substance use services

At the Becker's Fall Behavioral Health Summit, taking place November 4–5 in Chicago, behavioral health leaders and executives will explore strategies for expanding access to care, integrating services, addressing workforce challenges and leveraging innovation to improve outcomes across the behavioral health continuum. Apply for complimentary registration now.

Advertisement

Next Up in Research & Analysis

Advertisement